Progyny, Inc. (NASDAQ:PGNY) Director Cheryl Scott Sells 2,675 Shares

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) Director Cheryl Scott sold 2,675 shares of the company's stock in a transaction on Wednesday, June 11th. The shares were sold at an average price of $22.07, for a total value of $59,037.25. Following the completion of the transaction, the director now directly owns 14,112 shares in the company, valued at approximately $311,451.84. This trade represents a 15.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Progyny Stock Down 2.1%

Shares of PGNY traded down $0.46 during mid-day trading on Friday, hitting $21.09. The stock had a trading volume of 196,330 shares, compared to its average volume of 1,701,267. Progyny, Inc. has a fifty-two week low of $13.39 and a fifty-two week high of $30.42. The company's fifty day simple moving average is $21.97 and its two-hundred day simple moving average is $20.54. The company has a market cap of $1.81 billion, a PE ratio of 36.39, a PEG ratio of 2.39 and a beta of 1.32.

Progyny (NASDAQ:PGNY - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.28). Progyny had a net margin of 5.03% and a return on equity of 11.36%. The company had revenue of $324.04 million for the quarter, compared to analyst estimates of $307.86 million. During the same period in the previous year, the business posted $0.17 EPS. The firm's quarterly revenue was up 16.5% on a year-over-year basis. Equities analysts expect that Progyny, Inc. will post 0.6 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of PGNY. Baillie Gifford & Co. increased its holdings in Progyny by 52.2% in the 4th quarter. Baillie Gifford & Co. now owns 1,332,690 shares of the company's stock valued at $22,989,000 after buying an additional 456,853 shares during the period. PNC Financial Services Group Inc. lifted its position in shares of Progyny by 129.5% during the fourth quarter. PNC Financial Services Group Inc. now owns 19,967 shares of the company's stock worth $344,000 after purchasing an additional 11,268 shares in the last quarter. Cerity Partners LLC acquired a new stake in Progyny in the fourth quarter worth about $229,000. Voya Investment Management LLC grew its holdings in Progyny by 1.4% during the 4th quarter. Voya Investment Management LLC now owns 51,792 shares of the company's stock worth $893,000 after acquiring an additional 701 shares during the period. Finally, Acuitas Investments LLC acquired a new position in shares of Progyny in the 4th quarter valued at $2,980,000. 94.93% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. BTIG Research upgraded Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price objective on the stock in a research note on Monday, March 31st. Canaccord Genuity Group reduced their target price on Progyny from $23.00 to $21.00 and set a "hold" rating for the company in a report on Monday, May 12th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $23.45.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.